Skip to main content
SpringerLink
Log in

New approaches to the treatment and prevention of neurally mediated reflex (neurocardiogenic) syncope

  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Neurally mediated reflex syncope (sometimes referred to as neurocardiogenic syncope), encompasses a group of disorders of which the best known and most frequently occurring forms are the vasovagal (or common) faint, and carotid sinus syndrome. Postmicturition syncope, defecation syncope, cough syncope, and other situational reflex faints are also included among these conditions. With the exception of carotid sinus syndrome in which cardiac pacing is effective, treatment of most neurally mediated reflex faints is shifting from reliance on various drugs to greater emphasis on education and nonpharmacologic therapy. Initial management should include counseling of patients regarding recognition of early warning symptoms, and avoidance of precipitating factors. Volume expansion with salt tablets or electrolyte-containing beverages and patient education on how to perform isometric arm contractions and/or leg crossing in order to abort impending syncope are also important. Thereafter, tilt-training has demonstrated benefit in several clinical studies. When symptoms remain despite the above-noted interventions, pharmacologic therapy with midodrine or a nonselective à-blocker can be considered. the case of most neurally mediated reflex faints, permanent cardiac pacing should be reserved only for those older patients with significant bradycardia or asystole at time of syncope when all other interventions have failed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Brignole M, Alboni P, Benditt DG, et al.: Guidelines on management (bddiagnosis and treatment) of syncope. Eur Heart J 2001, 22:1256–1306. The ESC Task Force on Syncope provides the most important single reference source for recommended approaches to diagnosis and treatment of all forms of syncope. This document is updated periodically, and provides ready access to the most important literature on the subject.

    Article  PubMed  CAS  Google Scholar 

  2. Blanc J-J, Benditt DG: Syncope: definition, classification, and multiple potential causes. In The Evaluation and Treatment of Syncope. A Handbook for Clinical Practice. Edited by Benditt DG, Blanc J-J, Brignole M, Sutton RS. Elmsford, NY: Futura/Blackwell; 2003:3–10.

    Google Scholar 

  3. Benditt DG, Ferguson DW, Grubb BP, et al.: Tilt table testing for assessing syncope. ACC expert consensus document. J Am Coll Cardiol 1996, 28:263–275.

    Article  PubMed  CAS  Google Scholar 

  4. Soteriades ES, Evans JC, Larson MG, et al.: Incidence and Prognosis of Syncope. N Engl J Med 2002, 347:878–885. This manuscript, based on Framingham data, provides important insight into the natural history of syncope. The reader must beware, however, that the authors of the report mistakenly include neurologic causes of syncope, suggesting that they have not clearly separated syncope from other nonsyncope causes of transient loss of consciousness such as seizures. With that caveat in mind, the report does provide important follow-up information of clinical value.

    Article  PubMed  Google Scholar 

  5. Singh SD, Williams AJ: The prevalence and incidence of medical conditions in healthy pharmaceutical company employees who volunteer to participate in medical research. Br J Clin Pharmacol 1999, 48:25–31.

    Article  PubMed  CAS  Google Scholar 

  6. Reybrouck T, Heidbuchel H, Van de Werf F, et al.: Tilt training: a treatment for malignant and recurrent neurocardiogenic syncope. Pacing Clin Electrophysiol 2000, 23:493–498. A landmark report introducing tilt training as a useful strategy in the treatment of neurally mediated reflex faints.

    Article  PubMed  CAS  Google Scholar 

  7. Di Girolamo E, Di Iorio C, Leonzio L, et al.: Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: a controlled study. Circulation 1999, 100:1798–1801.

    PubMed  Google Scholar 

  8. Abe H, Kondo S, Kohshi K, et al.: Usefulness of orthostatic self-training for the prevention of neurocardiogenic syncope. Pacing Clin Electrophysiol 2002, 25:1454–1458.

    Article  PubMed  Google Scholar 

  9. Abe H, Kohshi K, Nakashima Y: Efficacy of orthostatic selftraining in medically refractory neurocardiogenic syncope. Clin Exper Hypertens 2003, 25:487–493.

    Article  Google Scholar 

  10. Reybrouck T, Heidbuchel H, Van de Werf F, et al.: Long-term follow-up results of tilt training therapy in patients with recurrent neurocardiogenic syncope. Pacing Clin Electrophysiol 2002, 25:1441–1446.

    Article  PubMed  Google Scholar 

  11. Krediet CT, van Dijk N, Linzer M, et al.: Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. Circulation 2002, 106:1684–1689. An important study revealing the value of a simple maneuver (legcrossing with muscle straining) for aborting an imminent reflex faint.

    Article  PubMed  Google Scholar 

  12. Brignole M, Croci F, Menozzi C, et al.: Isometric arm counterpressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol 2002, 40:2053–2059.

    Article  PubMed  Google Scholar 

  13. Brignole M, Donateo P, Menozzi C: The diagnostic value of ATP testing in patients with unexplained syncope. Europace 2003, 5:425–428.

    Article  PubMed  CAS  Google Scholar 

  14. Kenny RA, Bayliss J, Ingram A, et al.: Head up tilt: a useful test for investigating unexplained syncope. Lancet 1986, 1:1352–1354. The initial landmark paper introducing tilt table testing as a key diagnostic tool for evaluation of neurally mediated syncope.

    PubMed  CAS  Google Scholar 

  15. Perez-Paredes M, Pico-Aracil F, Floenciano R, et al.: Head-up tilt test in patients with high prestest likelihood of neurally mediated syncope: an approximation to the “real sensitivity” of this testing. Pacing Clin Electrophysiol 1999, 22:1173–1178.

    Article  PubMed  CAS  Google Scholar 

  16. Benditt DG, Ferguson DW, Grubb BP, et al.: Tilt table testing for syncope. American College of Cardiology. J Am Coll Cardiol 1996, 28:263–275. Although not a guideline statement, this is the closest publication to guideline that there is in the North American literature dealing with the neurally mediated syncope evaluation.

    Article  PubMed  CAS  Google Scholar 

  17. Brignole M, Alboni P, Benditt DG, et al.: Guidelines on management (diagnosis and treatment) of syncope. Eur Heart 2001, 22:1256–1306.

    Article  CAS  Google Scholar 

  18. Younoszai AK, Franklin WH, Chan DP, et al.: Oral fluid therapy. A promising treatment for vasodepressor syncope. Arch Pediatr Adolesc Med 1998, 152:165–168.

    PubMed  CAS  Google Scholar 

  19. Ector H, Reybrouck T, Heidbuchel H, et al.: Tilt training: a new treatment for recurrent neurocardiogenic syncope or severe orthostatic intolerance. Pacing Clin Electrophysiol 1998, 21:193–196.

    Article  PubMed  CAS  Google Scholar 

  20. Abe H, Sumiyoshi M, Kohshi K, et al.: Effects of orthostatic selftraining on head-up tilt testing for the prevention of tiltinduced nearocardiogenic syncope: comparison of pharmocological therapy. Clin Exper Hypertens 2003, 25:191–198.

    Article  Google Scholar 

  21. Brignole M, Alboni P, Benditt D, et al.: Task force on syncope, European Society of Cardiology. Part II. Diagnostic tests and treatment: summary of recommendations. Europace 2001, 3:261–268.

    Article  PubMed  CAS  Google Scholar 

  22. Krediet CT, van Dijk N, Linzer M, et al.: Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. Circulation 2002, 106:1684–1689.

    Article  PubMed  Google Scholar 

  23. Brignole M, Croci F, Menozzi C, et al.: Isometric arm counterpressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol 2002, 40:2053–2059.

    Article  PubMed  Google Scholar 

  24. Ditto B, Wilkins JA, France CR, et al.: On-site training in applied muscle tension to reduce vasovagal reactions to blood donation. J Behav Med 2003, 6:53–65.

    Article  Google Scholar 

  25. Melby DP, Lu F, Sakaguchi S, et al.: A novel inspiratory impedance device may diminish orthostatic intolerance. Heart Rhythm 2004, 1(Suppl 1):227.

    Google Scholar 

  26. Benditt DG, Fahy GJ, Lurie KG, et al.: Pharmacotherapy of neurally mediated syncope. Circulation 1999, 100:1242–1248.

    PubMed  CAS  Google Scholar 

  27. Fitzpatrick AP, Ahmed R, Williams S, et al.: A randomized trial of medical therapy in malignant vasovagal syndrome or neurally mediated bradycardia/hypotension syndrome. Eur Card Pacing Electrophysiol 1991, 1:191–202.

    Google Scholar 

  28. Brignole M, Menozzi C, Gianfranchi L, et al.: A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 1992, 70:339–342.

    Article  PubMed  CAS  Google Scholar 

  29. Mahanonda N, Bhuripanyo K, Kangkagate C, et al.: Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J 1995, 130:1250–1253.

    Article  PubMed  CAS  Google Scholar 

  30. Sheldon R, Rose S, Flanagan P, et al.: Effects of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test. Am J Cardiol 1996, 78:536–539.

    Article  PubMed  CAS  Google Scholar 

  31. Biffi M, Boriani G, Sabbatani P, et al.: Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine. Heart 1997, 77:268–272.

    Article  PubMed  CAS  Google Scholar 

  32. Iskos D, Dutton J, Scheinman MM, et al.: Usefulness of pindolol in neurocardiogenic syncope. Am J Cardiol 1998, 82:1121–1124.

    Article  PubMed  CAS  Google Scholar 

  33. Ward CR, Gray JC, Gilroy JJ, et al.: Midodrine: a role in the management of neurocardiogenic syncope. Heart 1998, 79:45–49.

    PubMed  CAS  Google Scholar 

  34. Di Girolamo E, Di Iorio C, Sabatini P, et al.: Effects of different treatments vs no treatment on neurocardiogenic syncope. Cardiologia 1998, 43:833–837.

    PubMed  Google Scholar 

  35. Raviele A, Brignole M, Sutton R, et al.: Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study. Circulation 1999, 99:1452–1457.

    PubMed  CAS  Google Scholar 

  36. Perez-Lugones A, Schweikert R, Pavia S, et al.: Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study. J Cardiovasc Electrophysiol 2001, 12:935–938.

    Article  PubMed  CAS  Google Scholar 

  37. Samniah N, Sakaguchi S, Lurie KG, et al.: Efficacy and safety of midodrine hydrochloride in patients with refractory vasovagal syncope. Am J Cardiol 2001, 88:80–83.

    Article  CAS  Google Scholar 

  38. Di Girolamo E, Di Iorio C, Sabatini P, et al.: Effects of different treatments versus no treatment on neurocardiogenic syncope. Cardiologia 1998, 43:833–837.

    PubMed  Google Scholar 

  39. Kaufmann H, Saadia D, Voustianiouk A: Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study. Ann Neurol 2002, 52:342–345.

    Article  PubMed  CAS  Google Scholar 

  40. Dendi R, Goldstein DS: Meta-analysis of nonselective versus beta-1 adrenoceptor-selective blockade in prevention of tiltinduced neurocardiogenic syncope. Am J Cardiol 2002, 89:1319–1321.

    Article  PubMed  CAS  Google Scholar 

  41. Benditt DG, Sutton R, Gammage M, et al.: Rate-Drop Response Investigators Group. Rate-drop response cardiac pacing for vasovagal syncope. J Interv Card Electrophysiol 1999, 3:27–33.

    Article  PubMed  CAS  Google Scholar 

  42. Connolly SJ, Sheldon R, Roberts RS, et al.: Vasovagal pacemaker study investigators. The North American vasovagal pacemaker study (VPS): a randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999, 33:16–20.

    Article  PubMed  CAS  Google Scholar 

  43. Sutton R, Brignole M, Menozzi C, et al.: Dual-chamber pacing in treatment of neurally mediated tilt-positive cardioinhibitory syncope. Pacemaker versus no therapy: a multicentre randomized study. Circulation 2000, 102:294–299.

    PubMed  CAS  Google Scholar 

  44. Ammirati F, Colivicchi F, Santini M, et al.: Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope. A multicenter, randomized, controlled trial. Circulation 2001, 104:52–56.

    PubMed  CAS  Google Scholar 

  45. Connolly S, Sheldon R, Thorpe KE, et al.: Pacemaker therapy for prevention of syncope in patients with recurrent vasovagal syncope. JAMA 2003, 289:2224–2229. Randomized, controlled study evaluating the efficacy of pacemaker therapy in patients with recurrent vasovagal syncope. Results showed a nonsignificant reduction in time to recurrent syncope in the pacemaker group.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Division, Department of Medicine, University of Minnesota Medical School, 420 Delaware Street SE, MMC 508, 55455, Minneapolis, MN, USA

    David G. Benditt MD

Authors
  1. Daniel P. Melby MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph A. Cytron MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David G. Benditt MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Melby, D.P., Cytron, J.A. & Benditt, D.G. New approaches to the treatment and prevention of neurally mediated reflex (neurocardiogenic) syncope. Curr Cardiol Rep 6, 385–390 (2004). https://doi.org/10.1007/s11886-004-0042-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-004-0042-7

Keywords

Search

Navigation